Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for 
anticancer treatment

Wolf, Siglinde

Local TagsRelease HistoryDetailsSummary

Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment

Wolf, S. (2012). Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment. PhD Thesis, Technische Universität, München.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-AC77-7 Version Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-AC78-5

Genre: Thesis

Files

show Files

Locators

show

Creators

show

hide

Creators:
Wolf, Siglinde¹, Author

Affiliations:
1Huber, Robert / Structure Research, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565155

Content

show

Details

show

hide

Language(s): eng - English

Dates: Accepted: 2012

Publication Status: Accepted / In Press

Pages: -

Publishing info: München : Technische Universität

Table of Contents: -

Rev. Type: -

Identifiers: -

Degree: PhD

Event

show

Legal Case

show

Project information

show

Source

show